DMPI Market Cap History
Below is a table of the DMPI market cap history going back to 5/20/2016:

Date DMPI Market Cap
5/20/201654.44M
7/12/201694.59M
9/12/201672.63M
11/10/201642.73M
2/9/201747.18M
5/12/201731.77M
9/27/201719.40M
11/8/201717.80M
2/13/201829.16M
5/14/201821.13M
9/21/201818.02M
11/13/201813.99M
2/11/20199.80M
5/8/20199.67M
5/14/20197.11M
9/6/20197.17M
2/12/20206.19M
5/12/20207.34M

Also see: DMPI Shares Outstanding History
and DMPI YTD Return
DMPI Historical Market Cap:
-39.56% CAGR
DMPI Historical Market Cap: +-39.56% CAGR

Mouse over chart for data details
5/20/2016 ...5/12/2020
DelMar Pharmaceuticals is a clinical stage, biopharmaceutical company. Co. is developing VAL-083, a DNA-targeting agent, for the treatment of drug-resistant solid tumors such as glioblastoma multiforme (GBM) and other solid tumors, including ovarian cancer and non-small cell lung cancer. Co. is also conducting open-label, biomarker driven studies in methyl guanine methyltransferase-unmethylated GBM. In addition to its clinical development activities in the United States, Co. has provided Guangxi Wuzhou Pharmaceutical (Group) Co. Ltd. certain commercial rights to VAL-083 in China where it is approved as a chemotherapy for the treatment of chronic myelogenous leukemia and lung cancer. We show 18 historical shares outstanding datapoints in our DMPI shares outstanding history coverage, used to compute DMPI market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing DMPI market cap history over the course of time is important for investors interested in comparing DMPI's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of DMPI versus a peer is one thing; comparing DMPI market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like DMPI can fluctuate over the course of history. With this page we aim to empower investors researching DMPI by allowing them to research the DMPI market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for DMPI:
DMPI SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
DelMar Pharmaceuticals (DMPI) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

DOVA Market Cap History
DPLO Market Cap History
DRAD Market Cap History
DRIO Market Cap History
DRNA Market Cap History
DRRX Market Cap History
DVA Market Cap History
DVAX Market Cap History
DVCR Market Cap History
DXCM Market Cap History
More Healthcare companies »

 

DMPI Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2020, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.